Unit 6, Wheatcroft Business Park Landmere Lane Nottingham NG12 4DG UK [t] 01279 408 210
Exco InTouch is a leading provider of digital patient engagement and data capture for clinical research and healthcare providers. Using a combination of software and services, Exco InTouch provides simple, secure channels of communication; facilitating the collection of quality data and improving outcomes for sponsors, clinical research organizations, sites and patients.
Working across clinical and late phase trials and mHealth programmes, Exco InTouch’s device independent approach enables involvement which integrates into daily life - resulting in motivated and compliant patients, reducing costs associated with withdrawals from trials and improving overall program results.
Exco InTouch, having pioneered mobile technology, increasing retention and compliance through engaging and supporting patients, and facilitating the delivery of ePRO via mobile devices, is now publishing public-facing apps on all three mobile operating platforms (iOS, Android and Windows8).
Exco InTouch, the leading provider of mobile patient communication and management solutions for the pharmaceutical and healthcare sector, is receiving an initial £3 million pound investment led by leading growth equity and venture capital group Scottish Equity Partners (SEP).
In collaboration with The University of Queensland, Exco InTouch conducts an evaluation of mobile phone technology for independent remote data capture, using the Western Ontario and McMaster Osteoarthritis (WOMAC) NRS 3.1 Index.
Exco InTouch is to partner with US-headquartered MMG, an international industry leader in patient enrolment for clinical trials, to enhance the efficacy of patient recruitment and retention services for pharmaceutical sponsors.
Exco InTouch has release a new technical paper which has been developed with the Centre of National Research on Disability and Rehabilitation Medicine (CONROD) at the University of Queensland and focuses on a preliminary evaluation of cellular technology in capturing the Western Ontario and McMaster University Osteoarthritis (WOMAC) NRS 3.1 Index data using mobile telephones.
Exco InTouch has partnered with London-based Logos Technologies, experts in early phase EDC and Phase I site automation, to develop an integrated system which speeds up the patient recruitment process.
Exco InTouch has introduced the REACT clinical trial communication system that uses the Short Message Service (SMS) to send scheduled, action-driven text messages directly to the mobile phone user, enhancing volunteer relationship management.